Hantai Pharma AsiaTirzepatide
Ordered Tirzepatide from Hantai Pharma Asia? Mail in a sample (US only) and let us test it.
Test my supplyHantai Pharma Asia tirzepatide has a mixed purity-focused record, with severe 63% and 75.8% purity misses despite identity passes. Other assays reached 99.9%, but same-day testing and repeated underfill keep batch consistency in focus.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Hantai Pharma Asia rows.
Cancel anytime
About Hantai Pharma Asia test results from Finnrick
Hantai Pharma Asia is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 6 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Hantai Pharma Asia peptides in this dataset are Tirzepatide (6 tests) and Retatrutide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 6 recent tests.
Ordered Tirzepatide from Hantai Pharma Asia? Mail in a sample (US only) and let us test it.
Test my supply